Shareholder Resolutions
Create and manage shareholder resolutions
| Name | Fund | Status | Due date | Responses | |
|---|---|---|---|---|---|
Annual Budget Approval 2025 Approval of the annual operating budget and capital expenditure plan for FY2025. |
Acorn Capital | Open | Apr 7, 2025 |
18/24 | |
Dividend Distribution Q1 Q1 dividend distribution to all limited partners per ownership percentage. |
Novara Ventures | Overdue | Mar 28, 2025 |
9/20 | |
Management Fee Waiver — Fund III Waive management fees for co-investors above €10M commitment in Fund III. |
Mercer Partners | Open | Apr 15, 2025 |
22/22 | |
Portfolio Exit — Luminary SaaS Shareholder approval for secondary sale of Luminary SaaS at €120M implied valuation. |
Acorn Capital | Open | Apr 5, 2025 |
11/24 | |
ESG Reporting Framework Adoption SFDR Article 8 compliant ESG reporting across all portfolio companies in Fund IV. |
Halcyon Bridge | Closed | Mar 10, 2025 |
16/16 | |
GP Removal Rights Amendment LPA update to align GP removal clauses with ILPA Principles 3.0 recommendations. |
Novara Ventures | Open | Apr 22, 2025 |
5/20 | |
Co-Investment SPV — Verity Health Establish a co-investment vehicle for Verity Health Series B at €2M minimum ticket. |
Mercer Partners | Closed | Feb 14, 2025 |
19/22 | |
Carried Interest Allocation — Fund IV Approval of carried interest waterfall and distribution schedule for Fund IV LPs. |
Halcyon Bridge | Open | Apr 9, 2025 |
3/18 | |
LP Advisory Committee Consent Consent from LP advisory committee for proposed amendments to fund governance terms. |
Acorn Capital | Overdue | Mar 20, 2025 |
6/24 | |
Side Letter Acknowledgement — NV III LP acknowledgement of side letter terms for Novara Ventures Fund III closing. |
Novara Ventures | Open | Apr 28, 2025 |
14/20 | |
Co-Investment Consent — Project Falcon LP consent for co-investment opportunity in Project Falcon at agreed terms. |
Acorn Capital | Closed | Feb 28, 2025 |
22/22 | |
Extension Period Approval — Fund IV LP approval for 12-month investment period extension under Section 8.3 of the LPA. |
Halcyon Bridge | Open | May 2, 2025 |
7/18 | |
Key Person Waiver — Growth Fund Resolution to waive key person provisions following appointment of new Managing Partner. |
Mercer Partners | Open | Apr 18, 2025 |
4/22 | |
Annual Accounts Sign-Off 2024 LP ratification of audited annual accounts for the financial year ending 31 December 2024. |
Novara Ventures | Closed | Jan 31, 2025 |
20/20 | |
Valuation Policy Amendment Consent to adopt revised fair value valuation policy in line with IPEV guidelines 2024. |
Halcyon Bridge | Overdue | Mar 15, 2025 |
2/18 |
Showing 1–10 of 15
